marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Spero Therapeutics Cash Flow 2011-2024 | SPRO
Annual Cash Flow Spero Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-33 M | -7.73 M | -64.3 M | -85.9 M | -50 M | -39.6 M | -39.1 M | -29 M | - | - | - | - | - |
Depreciation & Amortization |
367 K | 869 K | 646 K | 761 K | 750 K | 409 K | 363 K | 279 K | 11 K | - | - | - | - |
Accounts Payables |
1.38 M | 617 K | 1.1 M | 1.16 M | 4.15 M | 3.6 M | 3.47 M | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Spero Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | 5.94 M | - | - | - | -12.9 M | - | -52.2 M | -51.3 M | -28.2 M | - | -37 M | -32 M | -15.5 M | - | -69.5 M | -48.2 M | -23.3 M | - | -32.7 M | -23 M | -10.9 M | - | -26.1 M | -20.6 M | -12 M | - | -26.4 M | -15.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | - | 113 K | - | 740 K | 483 K | 189 K | - | 455 K | 307 K | 159 K | - | 570 K | 379 K | 189 K | - | 861 K | 372 K | 184 K | - | 270 K | 189 K | 95 K | - | 264 K | 170 K | 87 K | - | 194 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
6.09 M | 2.7 M | 3.07 M | 1.38 M | 1.1 M | 1.31 M | 583 K | 617 K | 2.58 M | 1.71 M | 4.78 M | 1.1 M | 3.16 M | 1.63 M | 3.82 M | 1.16 M | 1.16 M | 1.16 M | 1.16 M | 4.15 M | 4.15 M | 4.15 M | 4.15 M | 3.6 M | 3.6 M | 3.6 M | 3.6 M | 3.47 M | 3.47 M | 3.47 M | 3.47 M | 1.14 M | 1.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency